683 Capital Management »

C4 Therapeutics shares owned by 683 Capital Management

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $314k 56k 5.65

More positions owned by 683 Capital Management

Tesla Motors Put Option (TSLA)
Capital One Financial (COF)
BorgWarner (BWA)
Ero Copper Corp (ERO)
Hilton Grand Vacations (HGV)
Carvana Cl A (CVNA)
Sharkninja Com Shs (SN)
Occidental Pete Corp *w Exp 08/03/202 (OXY.WS)
Enova Intl (ENVA)
Tg Therapeutics (TGTX)
Wave Life Sciences SHS (WVE)
Ge Healthcare Technologies I Common Stock (GEHC)
Citigroup Com New (C)
Xenia Hotels & Resorts (XHR)
Ryder System (R)

View all positions for 683 Capital Management

Top funds holding C4 Therapeutics

RA Capital Management
Daniel D. Thurber
Commodore Capital
Lynx1 Capital Management
T. Rowe Price Associates
Arrowpoint Asset Management
Vanguard Group
Point72 Asset Management
Soleus Capital Management
Balyasny Asset Management
Bank of America Corporation
Marshall Wace
Millennium Management
Citadel Advisors
Cubist Systematic Strategies

View all funds holding C4 Therapeutics